Search Results - "PIRAGS, Valdis"
-
1
Achievement of treatment targets predicts progression of vascular complications in type 1 diabetes
Published in Journal of diabetes and its complications (01-12-2021)“…To study the association between achievement of guideline-defined treatment targets on HbA1c, low-density lipoproteins (LDL-C), and blood pressure with the…”
Get full text
Journal Article -
2
Fatty liver index and hepatic steatosis index for prediction of non-alcoholic fatty liver disease in type 1 diabetes
Published in Journal of gastroenterology and hepatology (01-01-2018)“…Little is known about the diagnostic value of hepatic steatosis index (HSI) and fatty liver index (FLI), as well as their link to metabolic syndrome in type 1…”
Get full text
Journal Article -
3
Comparative Analysis of Predictive Interstitial Glucose Level Classification Models
Published in Sensors (Basel, Switzerland) (01-10-2023)“…Background: New methods of continuous glucose monitoring (CGM) provide real-time alerts for hypoglycemia, hyperglycemia, and rapid fluctuations of glucose…”
Get full text
Journal Article -
4
Association of metformin administration with gut microbiome dysbiosis in healthy volunteers
Published in PloS one (27-09-2018)“…Metformin is a widely used first-line drug for treatment of type 2 diabetes. Despite its advantages, metformin has variable therapeutic effects,…”
Get full text
Journal Article -
5
Report on Bariatric Surgery in Latvia
Published in Obesity surgery (01-05-2021)Get full text
Journal Article -
6
Baseline gut microbiome composition predicts metformin therapy short-term efficacy in newly diagnosed type 2 diabetes patients
Published in PloS one (30-10-2020)“…The study was conducted to investigate the effects of metformin treatment on the human gut microbiome's taxonomic and functional profile in the Latvian…”
Get full text
Journal Article -
7
Metformin strongly affects transcriptome of peripheral blood cells in healthy individuals
Published in PloS one (08-11-2019)“…Metformin is a commonly used antihyperglycaemic agent for the treatment of type 2 diabetes mellitus. Nevertheless, the exact mechanisms of action, underlying…”
Get full text
Journal Article -
8
Whole exome sequencing reveals novel risk genes of pituitary neuroendocrine tumors
Published in PloS one (26-08-2022)“…Somatic genetic alterations in pituitary neuroendocrine tumors (PitNET) tissues have been identified in several studies, but detection of overlapping somatic…”
Get full text
Journal Article -
9
Association of Endotoxemia with Low-Grade Inflammation, Metabolic Syndrome and Distinct Response to Lipopolysaccharide in Type 1 Diabetes
Published in Biomedicines (01-12-2023)“…The association of endotoxemia with metabolic syndrome (MS) and low-grade inflammation in type 1 diabetes (T1D) is little-studied. We investigated the levels…”
Get full text
Journal Article -
10
Whole-blood transcriptome profiling reveals signatures of metformin and its therapeutic response
Published in PloS one (11-08-2020)“…Metformin, a biguanide agent, is the first-line treatment for type 2 diabetes mellitus due to its glucose-lowering effect. Despite its wide application in the…”
Get full text
Journal Article -
11
Similar cardiovascular outcomes in patients with diabetes and established or high risk for coronary vascular disease treated with dulaglutide with and without baseline metformin
Published in European heart journal (08-07-2021)“…Abstract Objective Recent European Guidelines for Diabetes, Prediabetes and Cardiovascular Diseases introduced a shift in managing patients with type 2…”
Get full text
Journal Article -
12
Evaluating Personalized Add-On Ayurveda Therapy in Oxygen-Dependent Diabetic COVID-19 Patients: A 60-Day Study of Symptoms, Inflammation, and Radiological Changes
Published in Curēus (Palo Alto, CA) (01-09-2024)“…Background Effective management of both acute and post-acute sequelae of SARS-CoV-2 is essential, particularly for type 2 diabetes mellitus (T2DM) patients,…”
Get full text
Journal Article -
13
A Prospective, Controlled, Pilot Study of Personalised Add-on Ayurveda Treatment in High-Risk Type II Diabetes COVID-19 Patients
Published in Journal of herbal medicine (01-02-2024)Get full text
Journal Article -
14
From classical dualistic antagonism to hormone synergy: potential of overlapping action of glucagon, insulin and GLP-1 for the treatment of diabesity
Published in Endocrine Connections (01-05-2024)“…The increasing prevalence of 'diabesity', a combination of type 2 diabetes and obesity, poses a significant global health challenge. Unhealthy lifestyle…”
Get full text
Journal Article -
15
The oxygenation module: the missing link in using sleep apnea devices to treat COVID-19 pneumonia at home
Published in Biomedical engineering online (04-02-2022)“…The study aims at solving the problem with the limitations of the homecare CPAP equipment such as sleep apnea devices in the treatment of COVID-19 pneumonia…”
Get full text
Journal Article -
16
Novel susceptibility loci identified in a genome-wide association study of type 2 diabetes complications in population of Latvia
Published in BMC medical genomics (11-01-2021)“…Type 2 diabetes complications cause a serious emotional and economical burden to patients and healthcare systems globally. Management of both acute and chronic…”
Get full text
Journal Article -
17
Gut microbiome encoded purine and amino acid pathways present prospective biomarkers for predicting metformin therapy efficacy in newly diagnosed T2D patients
Published in Gut microbes (01-01-2024)“…Metformin is widely used for treating type 2 diabetes mellitus (T2D). However, the efficacy of metformin monotherapy is highly variable within the human…”
Get full text
Journal Article -
18
Phase 2 trial with imeglimin in patients with Type 2 diabetes indicates effects on insulin secretion and sensitivity
Published in Endocrinology, diabetes & metabolism (01-11-2022)“…Introduction The aim of the present study was to evaluate the effect of 18‐week monotherapy with imeglimin on glucose tolerance and on insulin…”
Get full text
Journal Article -
19
Single nucleotide polymorphisms in the intergenic region between metformin transporter OCT2 and OCT3 coding genes are associated with short-term response to metformin monotherapy in type 2 diabetes mellitus patients
Published in European journal of endocrinology (01-12-2016)“…Objective(s) High variability in clinical response to metformin is often observed in type 2 diabetes (T2D) patients, and it highlights the need for…”
Get full text
Journal Article -
20
Hypercalcemia and CYP24A1 Gene Mutation Diagnosed in the 2nd Trimester of a Twin Pregnancy: A Case Report
Published in The American journal of case reports (18-10-2021)“…Patient: Female, 33-year-old Final Diagnosis: Hypercalcemic crisis • pregnancy Symptoms: Hypercalcemia • hypertension • hypertensive crisis • pregnancy…”
Get full text
Journal Article